Immediate Impact
48 standout
Citing Papers
Gastric cancer treatment: recent progress and future perspectives
2023 Standout
Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Progress, Challenges, and Prospects
2022 Standout
Works of Åsa Dahle-Smith being referenced
Epidermal Growth Factor (EGFR) copy number aberrations in esophageal and gastro-esophageal junctional carcinoma
2015
Patient-reported outcomes from a phase III multicenter, randomized, double-blind, placebo-controlled trial of gefitinib versus placebo in esophageal cancer progressing after chemotherapy: Cancer Oesophagus Gefitinib (COG).
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Åsa Dahle-Smith | 29 | 38 | 26 | 7 | 46 | |
| Fabiana Sousa | 18 | 31 | 24 | 8 | 52 | |
| M Varcada | 46 | 20 | 21 | 6 | 59 | |
| Isabel Cuenca | 30 | 31 | 17 | 5 | 45 | |
| Carlos Adame | 12 | 39 | 28 | 7 | 55 | |
| Erica Mazzotta | 40 | 13 | 12 | 7 | 58 | |
| Fabio Pulighe | 36 | 14 | 30 | 9 | 62 | |
| Jean-Christophe Saurin | 27 | 32 | 17 | 8 | 51 | |
| Isabel Alemany | 16 | 16 | 11 | 6 | 46 | |
| Stephen McCain | 26 | 18 | 15 | 11 | 55 | |
| Anne Miek Koenen | 10 | 24 | 16 | 6 | 44 |
All Works
Loading papers...